NO20021295L - Nikotinsyreacetylcholin-reseptor - Google Patents

Nikotinsyreacetylcholin-reseptor

Info

Publication number: NO20021295L
Authority: NO; Norway
Prior art keywords: nikotinsyreacetylcholin; receptor; nikotinsyreacetylcholin receptor
Prior art date: 1999-09-15

Application number

NO20021295A

Other languages

English (en)

Norwegian (no)

Other versions

NO20021295D0 (no

Inventor

Jeffrey Roland Yon

Christopher James Grantham

Paulus Johanne Groot-Kormelink

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-15

Filing date

2002-03-15

Publication date

2002-05-14

2000-02-02 Priority claimed from GB0002431A external-priority patent/GB0002431D0/en

2002-03-15 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-03-15 Publication of NO20021295D0 publication Critical patent/NO20021295D0/no

2002-05-14 Publication of NO20021295L publication Critical patent/NO20021295L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
Addiction (AREA)
Rheumatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)

NO20021295A 1999-09-15 2002-03-15 Nikotinsyreacetylcholin-reseptor NO20021295L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15394899P	1999-09-15	1999-09-15
GB0002431A GB0002431D0 (en)	2000-02-02	2000-02-02	Nicotinic acetylcholine receptor
PCT/EP2000/009115 WO2001019973A2 (fr)	1999-09-15	2000-09-14	Recepteur nicotinique de l'acetylcholine

Publications (2)

Publication Number	Publication Date
NO20021295D0 NO20021295D0 (no)	2002-03-15
NO20021295L true NO20021295L (no)	2002-05-14

Family

ID=26243551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021295A NO20021295L (no)	1999-09-15	2002-03-15	Nikotinsyreacetylcholin-reseptor

Country Status (10)

Country	Link
US (1)	US20060127914A1 (fr)
EP (1)	EP1218502A2 (fr)
JP (1)	JP2003509045A (fr)
KR (1)	KR20020059331A (fr)
AU (1)	AU780460B2 (fr)
CA (1)	CA2384294A1 (fr)
IL (1)	IL148667A0 (fr)
NO (1)	NO20021295L (fr)
NZ (1)	NZ516504A (fr)
WO (1)	WO2001019973A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1190708A1 (fr) *	2000-09-21	2002-03-27	Tinnitus Forschungs- und Entwicklungs GmbH	Utilisation médicale de substances
US8497081B2 (en)	2004-02-24	2013-07-30	Allergan, Inc.	Botulinum toxin screening assays
ATE533853T1 (de) *	2004-02-24	2011-12-15	Allergan Inc	Botulinumtoxin-screening-assays
WO2008011006A2 (fr)	2006-07-18	2008-01-24	University Of Utah Research Foundation	Procédé pour traiter la douleur et rechercher systématiquement des composés analgésiques
US9284358B2 (en)	2006-07-18	2016-03-15	University Of Utah Research Foundation	Conotoxin peptides
EP3512873B1 (fr) *	2016-09-08	2023-11-01	The Regents of The University of California	Peptides et leurs utilisations dans le diagnostic et le traitement de la myasthénie gravis
WO2020234179A1 (fr) *	2019-05-17	2020-11-26	Janssen Pharmaceutica Nv	Systèmes d'expression pour le récepteur nicotinique de l'acétylcholine alpha 9/alpha 10 et procédés d'utilisation associés

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5683912A (en) *	1994-07-21	1997-11-04	The Salk Institute For Biological Studies	Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit

2000
- 2000-09-14 JP JP2001523745A patent/JP2003509045A/ja not_active Withdrawn
- 2000-09-14 NZ NZ516504A patent/NZ516504A/en unknown
- 2000-09-14 AU AU75201/00A patent/AU780460B2/en not_active Ceased
- 2000-09-14 CA CA002384294A patent/CA2384294A1/fr not_active Abandoned
- 2000-09-14 IL IL14866700A patent/IL148667A0/xx unknown
- 2000-09-14 WO PCT/EP2000/009115 patent/WO2001019973A2/fr not_active Ceased
- 2000-09-14 KR KR1020027000369A patent/KR20020059331A/ko not_active Ceased
- 2000-09-14 EP EP00964193A patent/EP1218502A2/fr not_active Withdrawn
2002
- 2002-03-15 NO NO20021295A patent/NO20021295L/no not_active Application Discontinuation
2003
- 2003-11-20 US US10/718,933 patent/US20060127914A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001019973A3 (fr)	2001-09-27
IL148667A0 (en)	2002-09-12
EP1218502A2 (fr)	2002-07-03
WO2001019973A2 (fr)	2001-03-22
CA2384294A1 (fr)	2001-03-22
JP2003509045A (ja)	2003-03-11
AU780460B2 (en)	2005-03-24
NZ516504A (en)	2003-09-26
US20060127914A1 (en)	2006-06-15
NO20021295D0 (no)	2002-03-15
AU7520100A (en)	2001-04-17
KR20020059331A (ko)	2002-07-12

Publication	Publication Date	Title
ID26447A (id)	2001-01-04	Turunan eritropoietin
NO20016115L (no)	2002-02-12	Substituerte heterosykelkondenserte gamma-karbolin
PT1224180E (pt)	2003-11-28	Azois substituidos
DE60002992D1 (de)	2003-07-03	Dreiphasenabscheider
DE60005976D1 (de)	2003-11-20	Speicherkkarte
DE60017513D1 (de)	2005-02-24	Spritzenendstückkappe
DE60001240D1 (de)	2003-02-27	Laserdepiliergerät
DE60020629D1 (de)	2005-07-14	Kassettengleitringdichtung
NO20022856L (no)	2002-08-16	Adamtanderivater
DE60009430D1 (de)	2004-05-06	Türtülle
DE60008638D1 (de)	2004-04-08	Förderbandabstreicher
DE69932949D1 (de)	2006-10-05	Aufszugssteuerung
DE60015794D1 (de)	2004-12-16	Kompositverschlusskappe
NO20013997L (no)	2001-10-17	Reseptoranalyse
DE60001894T2 (de)	2004-01-29	Busschienenverbindungsstruktur
DE60017027D1 (de)	2005-02-03	Gehrungseinrichtung
DE50015451D1 (de)	2009-01-02	Spülwannensystem
DE60012576D1 (de)	2004-09-02	Spreizfaktorbestimmung
DE59910286D1 (de)	2004-09-23	Kniehebel-spannvorrichtung
DE60013054D1 (de)	2004-09-23	Reissverschlusszuglasche
ID30214A (id)	2001-11-15	Turunan resorsinol
DE69935066D1 (de)	2007-03-22	Befehlsvorausholeinheit
DE60028852D1 (de)	2006-08-03	Fixiervorrichtung
DE60023130D1 (de)	2005-11-17	Scharnierarmbefestigung
DE60033003D1 (de)	2007-03-08	Münzrollmaschine

Legal Events

Date	Code	Title	Description
2008-04-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application